Fourpath Capital Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$352K Buy
5,096
+1,444
+40% +$99.7K 0.06% 172
2025
Q1
$254K Buy
3,652
+346
+10% +$24K 0.04% 192
2024
Q4
$284K Buy
3,306
+306
+10% +$26.3K 0.05% 184
2024
Q3
$357K Buy
+3,000
New +$357K 0.07% 166